Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial

BACKGROUND/AIMS: Solifenacin, a muscarinic type 3 receptor antagonist, is used to treat overactive bladder in adults. The aim of this study is to examine the efficacy of solifenacin on the symptomatic relief of diarrhea predominant irritable bowel syndrome (IBS-D). METHODS: A total of 20 patients wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fukushima, Yasushi, Suzuki, Hidekazu, Matsuzaki, Juntaro, Kiyosue, Arihiro, Hibi, Toshifumi
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Society of Neurogastroenterology and Motility 2012
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3400820/
https://ncbi.nlm.nih.gov/pubmed/22837880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm.2012.18.3.317
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados